Publication | Open Access
Characterization and Complete Genome Sequence of a Novel Coronavirus, Coronavirus HKU1, from Patients with Pneumonia
1.5K
Citations
47
References
2004
Year
Viral DiagnosticsImmunologyViral PathogenesisPathologyCoronavirus Hku1Viral Structural ProteinCovid-19Respiratory Tract InfectionsViral EvolutionRespiratory InfectionVirus PhylogenyComplete Genome SequenceViral GeneticsSerum LevelsRespiratory DiseasesNovel CoronavirusVirologyImmunoglobulin MEmerging Infectious DiseasesPathogenesisInfectious Respiratory DiseaseMicrobiologyMedicine
Despite many respiratory infections lacking a known microbiological cause, several novel respiratory viruses—including SARS‑CoV and human coronavirus NL63—have been identified in the past three years. The authors screened 400 SARS‑negative nasopharyngeal aspirates from patients with respiratory illness during the SARS period and detected CoV‑HKU1 RNA in one specimen. We identified coronavirus HKU1 in a 71‑year‑old pneumonia patient, characterized its high viral load, antibody response, 29,926‑nt genome with the lowest GC content among coronaviruses, and phylogenetically placed it as a new group 2 virus, with additional detection in a second patient confirming its association with human pneumonia.
Despite extensive laboratory investigations in patients with respiratory tract infections, no microbiological cause can be identified in a significant proportion of patients. In the past 3 years, several novel respiratory viruses, including human metapneumovirus, severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV), and human coronavirus NL63, were discovered. Here we report the discovery of another novel coronavirus, coronavirus HKU1 (CoV-HKU1), from a 71-year-old man with pneumonia who had just returned from Shenzhen, China. Quantitative reverse transcription-PCR showed that the amount of CoV-HKU1 RNA was 8.5 to 9.6 x 10(6) copies per ml in his nasopharyngeal aspirates (NPAs) during the first week of the illness and dropped progressively to undetectable levels in subsequent weeks. He developed increasing serum levels of specific antibodies against the recombinant nucleocapsid protein of CoV-HKU1, with immunoglobulin M (IgM) titers of 1:20, 1:40, and 1:80 and IgG titers of <1:1,000, 1:2,000, and 1:8,000 in the first, second and fourth weeks of the illness, respectively. Isolation of the virus by using various cell lines, mixed neuron-glia culture, and intracerebral inoculation of suckling mice was unsuccessful. The complete genome sequence of CoV-HKU1 is a 29,926-nucleotide, polyadenylated RNA, with G+C content of 32%, the lowest among all known coronaviruses with available genome sequence. Phylogenetic analysis reveals that CoV-HKU1 is a new group 2 coronavirus. Screening of 400 NPAs, negative for SARS-CoV, from patients with respiratory illness during the SARS period identified the presence of CoV-HKU1 RNA in an additional specimen, with a viral load of 1.13 x 10(6) copies per ml, from a 35-year-old woman with pneumonia. Our data support the existence of a novel group 2 coronavirus associated with pneumonia in humans.
| Year | Citations | |
|---|---|---|
Page 1
Page 1